<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250523065853N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-06-28</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The Impact of Mindfulness-Based Stress Reduction on Anxiety and Problem-Solving in Students</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of Mindfulness-Based Stress Reduction on Anxiety Sensitivity and Problem-Solving Ability of Students</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-08-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84334</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Other design features: This study includes repeated measures with pre- and post-intervention assessments to evaluate changes over time. Random allocation is applied using block randomization to ensure group balance. The study also follows the intention-to-treat principle to maintain the integrity of statistical analysis, Randomization description: Participants will be randomly assigned to the intervention or control group using a computer-generated random sequence created by block randomization with a 1:1 allocation ratio. Block sizes will be fixed and generated in advance to ensure balanced group sizes throughout recruitment. Allocation concealment will be ensured using sealed, opaque, and sequentially numbered envelopes. The randomization list will be prepared and maintained by an independent researcher who is not involved in participant recruitment or assessment. This process aims to minimize selection bias and maintain allocation integrity, Blinding description: This study is double-blind. Participants are informed that the study involves two different educational programs and are not told which group is considered the intervention or the control. The sessions are presented as potentially beneficial stress management trainings. Outcome assessors, who administer pre- and post-intervention questionnaires, are not involved in delivering the sessions and are unaware of group assignments. Group codes are used during data collection and analysis to maintain blinding and minimize assessment bias.</study_design>
      <phase>N/A</phase>
      <hc_freetext>This study focuses on anxiety sensitivity, a psychological trait characterized by the fear of anxiety-related sensations due to beliefs that these sensations have harmful consequences. It is commonly associated with anxiety disorders, especially panic disorder..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants in this group will attend an eight-week Mindfulness-Based Stress Reduction (MBSR) program. The program includes weekly 90-minute group sessions. The content involves practical training in mindfulness practices such as body scan, breathing awareness, seated meditation, and mindful movement. Participants are instructed to perform daily home practice for 45 minutes. Audio files and written educational materials are provided. The sessions will be delivered by a trained and experienced instructor in mindfulness-based interventions. Intervention 2: Control group: Control group: Participants in this group will not receive any psychological intervention during the study period. They will be placed on a waiting list and offered the same MBSR training program after completing the post-intervention assessment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All the deidentified individual participant data, along with the study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code, and data dictionary will be shared with qualified researchers upon reasonable request. Data will be available after publication of main results for a period of 3 years. Requests should be sent via email to the principal investigator at. Data will be provided via institutional secure file-sharing platforms under appropriate ethical and legal agreements.

When:
The deidentified individual participant data (IPD) and related documents will be made available 6 months after publication of the main study results. The data will be available for a period of 3 years after that.

To whom:
The data will be shared with qualified researchers working in academic institutions, governmental organizations, or non-profit research centers. Researchers affiliated with industry may also apply under specific conditions.

Conditions:
Data may be used only for scientific research purposes, such as secondary analysis, meta-analysis, and validation studies.
Applicants must submit a research proposal, ethical approval, and sign a Data Use Agreement (DUA). All requests will be evaluated by a Data Access Committee (DAC).

Where to obtain:
Requests should be sent to the following contact:
Dr. Zahra Saeedi
Mashhad University of Medical Sciences
School of Medicine, Department of Psychology
Mashhad, Razavi Khorasan, Iran
Phone: +98 916 604 6877
Email: darya2674@gmail.com

How to obtain:
Applicants must submit:
A detailed research proposal
Ethical committee approval
A signed Data Use Agreement (DUA)
Requests will be reviewed by the Data Access Committee (DAC) within 4–6 weeks. If approved, data will be shared via secure digital transfer.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Saedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Psychology, School of Medicine, Pardis Daneshgah, Azadi Blvd, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948564</zip>
        <telephone>+98 916 604 6877</telephone>
        <email>darya2674@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Saedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Psychology, School of Medicine, Pardis Daneshgah, Azadi Blvd, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948564</zip>
        <telephone>+98 916 604 6877</telephone>
        <email>darya2674@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>University students aged between 18 and 35 years
Willingness to participate in the study and provide informed consent
Having moderate to high anxiety sensitivity based on the Anxiety Sensitivity Index (ASI)
Availability to attend all mindfulness sessions
Not currently participating in other psychological or psychiatric interventions
Basic literacy and ability to complete self-report questionnaires</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Current diagnosis of severe psychiatric disorders (e.g., psychosis, bipolar disorder)
Use of psychiatric medication during the intervention period
Participation in other psychological treatment programs concurrently
Absence from more than two mindfulness sessions
Any physical condition that prevents regular attendance or participation
Incomplete response to pre-test questionnaires</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Generalized anxiety disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants in this group will attend an eight-week Mindfulness-Based Stress Reduction (MBSR) program. The program includes weekly 90-minute group sessions. The content involves practical training in mindfulness practices such as body scan, breathing awareness, seated meditation, and mindful movement. Participants are instructed to perform daily home practice for 45 minutes. Audio files and written educational materials are provided. The sessions will be delivered by a trained and experienced instructor in mindfulness-based interventions.</i_keyword>
      <i_keyword>Control group: Control group: Participants in this group will not receive any psychological intervention during the study period. They will be placed on a waiting list and offered the same MBSR training program after completing the post-intervention assessment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The primary outcome is the change in anxiety sensitivity levels among students after undergoing mindfulness-based stress reduction (MBSR) intervention. Anxiety sensitivity will be measured using a validated questionnaire. Timepoint: Anxiety sensitivity will be measured at baseline (before the intervention), immediately after the intervention, and at 3 months follow-up. Method of measurement: Anxiety sensitivity will be assessed using the Anxiety Sensitivity Index (ASI), a validated self-report questionnaire.</prim_outcome>
      <prim_outcome>The secondary outcome is the change in problem-solving ability among students after mindfulness-based stress reduction intervention. Timepoint: Problem-solving ability will be measured at baseline, immediately after the intervention, and at 3 months follow-up. Method of measurement: Problem-solving ability will be assessed using a standardized and validated problem-solving inventory questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The secondary outcome is the change in problem-solving ability of students following the mindfulness-based stress reduction intervention. Timepoint: Measured at baseline, immediately after the intervention, and 3 months after the intervention. Method of measurement: Problem-solving ability will be assessed using a validated problem-solving inventory questionnaire.</sec_outcome>
      <sec_outcome>The secondary outcome is the change in perceived stress levels of students after mindfulness-based stress reduction intervention. Timepoint: Measured at baseline, immediately after the intervention, and at 3 months follow-up. Method of measurement: Perceived stress will be assessed using the Perceived Stress Scale (PSS), a validated self-report questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-05-26</approval_date>
        <contact_name>Ethics Committee of the School of Medicine, Mashhad University of Medical Sciences</contact_name>
        <contact_address>Mashhad University of Medical Sciences, Azadi Square, Mashhad, Iran Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
